tiprankstipranks
Trending News
More News >

Rami Katkhuda Profile - LifeSci Capital Analyst

144 Followers
tipranks
Rami Katkhuda

Rami Katkhuda
LifeSci Capital

Wall Street Analyst
#328 out of 10,026 Wall Street Analysts
#819 out of 42,037 experts

Success Rate

53%
104 out of 195 ratings made a profit

Average Return

+30.70%
Average return per rating
Time Frame
1 Year
Compare to
No Benchmark
Copying Rami Katkhuda's trades since 2023 and holding each position for 1 Year would result in 53.33% of your transactions generating a profit, with an average return of 30.7% per rating.

Stock Rating Distribution

258Ratings
98.06% Buy
1.94% Hold
0.00% Sell
Distribution of Rami Katkhuda's ratings

Additional Information

Main Sector:General
Geo Coverage:
United States

Best Rating

Stock:
Moonlake Immunotherapeutics
(MLTX)
Rating:Buy
Date:Dec 21, 2022 - Dec 21, 2023
Return:+496.20%
The most profitable rating made by Rami Katkhuda

Rami Katkhuda's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
CINC
Cincor Pharma
Jan 09, 2023
Hold
Initiated
5Ratings
100%
+2.30%
CALT
Calliditas Therapeutics
May 28, 2024
Hold
Downgraded
$39.00
(-2.50% Downside)
25Ratings
45%
+8.45%
Inventiva
Apr 02, 2025
Buy
Reiterated
$14.00
(149.11% Upside)
8Ratings
50%
+31.72%
MoonLake Immunotherapeutics
Aug 05, 2025
Buy
Reiterated
$75.00
(41.96% Upside)
29Ratings
67%
+54.84%
Vera Therapeutics
Aug 05, 2025
Buy
Reiterated
$70.00
(194.49% Upside)
28Ratings
48%
+64.15%
Viridian Therapeutics
Aug 06, 2025
Buy
Reiterated
$46.00
(142.36% Upside)
33Ratings
41%
+0.66%
Disc Medicine
Aug 07, 2025
Buy
Reiterated
$85.00
(41.71% Upside)
25Ratings
65%
+9.54%
Akero Therapeutics
Aug 11, 2025
Buy
Reiterated
$80.00
(83.15% Upside)
9Ratings
67%
+36.63%
VYNE Therapeutics
Aug 14, 2025
Hold
Reiterated
22Ratings
7%
-65.62%
Eledon Pharmaceuticals
Sep 04, 2025
Buy
Reiterated
$9.00
(268.10% Upside)
32Ratings
30%
+12.79%
List of latest recommendations made by Rami Katkhuda. Click to expand and see Rami Katkhuda's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Advertisement
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >

Rami Katkhuda activity FAQ

What is the performance of Rami Katkhuda's recommendations?
The percentage of profitable recommendations made by Rami Katkhuda is 53%, and the average return per transaction is 30.70%.
    What stocks does Rami Katkhuda cover?
    Rami Katkhuda mostly covers VRDN ,ELDN ,MLTX stocks.
      What was Rami Katkhuda's most profitable rating?
      Rami Katkhuda’s most profitable ratings was a buy on MLTX stock on Dec 21, 2022 - Dec 21, 2023. The return on the trade was +496.20%.
        Where can I see a list of stock analyst ratings?
        You can see a list of daily stock analyst ratings here.
          What are the most recommended stocks by analysts?
          You can see a list of the most recommended stocks by analysts here